Question 1

Does Allianz Asset Management own ABCL stock?

Accepted Answer

No. Allianz Asset Management exited its ABCL (AbCellera Biologics) position in Q2 2025. Its Q1 2025 13F listed 25,622 shares worth $60,468.

Question 2

How many shares of ABCL does Allianz Asset Management own?

Accepted Answer

None since Q2 2025, when Allianz Asset Management exited the position. Its Q1 2025 13F listed 25,622 shares worth $60,468.

Question 3

What is Allianz Asset Management's ABCL position worth?

Accepted Answer

Allianz Asset Management's ABCL position was worth $60,468 in its Q1 2025 13F, before the exit in Q2 2025.

Question 4

Is Allianz Asset Management buying or selling ABCL?

Accepted Answer

In Q2 2025, Allianz Asset Management exited its entire ABCL position.

Question 5

When did Allianz Asset Management first buy ABCL?

Accepted Answer

Allianz Asset Management first reported ABCL in its Q2 2021 13F and listed it in 10 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$3.43	0
2025-Q1	Increased	25,622	+121.3%	$60,468	0.0%	$2.23	34
2024-Q4	Decreased	11,578	-40.9%	$32,650	0.0%	$2.93	0
2024-Q3	Increased	19,593	+53.2%	$50,942	0.0%	$2.61	29